Search results for "Signal"

showing 10 items of 6924 documents

Steering of a Sub-GeV electron beam through planar channeling enhanced by rechanneling

2014

We report the observation of efficient steering of a 855 MeV electron beam at MAMI (MAinzer MIkrotron) facilities by means of planar channeling and volume reflection in a bent silicon crystal. A $30.5\text{ }\text{ }\ensuremath{\mu}\mathrm{m}$ thick plate of (211) oriented Si was bent to cause quasimosaic deformation of the (111) crystallographic planes, which were used for coherent interaction with the electron beam. The experimental results are analogous to those recorded some years ago at energy higher than 100 GeV, which is the only comparable study to date. Monte Carlo simulations demonstrated that rechanneling plays a considerable role in a particle's dynamics and hinders the spoiling…

electron beamEnergy rangesPlanar channelingBent molecular geometryGeneral Physics and AstronomyExtractionCrystallographic planeElectronX-ray sourcesCoherent interactionchanneling; electron beam; beam steerigbeam steerigMonocrystalline siliconPlanarNegative particlesA-particlesVolume reflectionCollimationPhysicsRange (particle radiation)Silicon crystalchannelingNegative particles; Bent crystals; Volume reflection; Deflection; Extraction; Collimation; A-particles; Coherent interaction; Crystallographic plane; Energy ranges; Planar channeling; Silicon crystal; X-ray sourcesReflection (mathematics)Cathode rayPhysics::Accelerator PhysicsAtomic physicsDeflectionBent crystalsEnergy (signal processing)
researchProduct

Improved calculations of beta decay backgrounds to new physics in liquid xenon detectors

2020

We present high-precision theoretical predictions for the electron energy spectra for the ground-state to ground-state $\beta$ decays of $^{214}$Pb, $^{212}$Pb, and $^{85}$Kr most relevant to the background of liquid xenon dark matter detectors. The effects of nuclear structure on the spectral shapes are taken into account using large-scale shell model calculations. Final spectra also include atomic screening and exchange effects. The impact of nuclear structure effects on the $^{214}$Pb and $^{212}$Pb spectra below $\approx100$ keV, pertinent for several searches for new physics, are found to be comparatively larger than those from the atomic effects alone. We find that the full calculatio…

electronElectron01 natural sciencesSpectral lineHigh Energy Physics - ExperimentspectrumHigh Energy Physics - Experiment (hep-ex)Xenon[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]beta-raysground stateNuclear Experiment (nucl-ex)Nuclear Experimentnuclear instrumentationPhysicsinstrumentationxenon: liquidnew physics: search forNuclear structureaxial-vectorsemileptonic decayCoupling (probability)simulation3. Good healthradioactivityGround stateionizing radiationSemileptonic decay[PHYS.NUCL]Physics [physics]/Nuclear Theory [nucl-th]energy spectrumFOS: Physical scienceschemistry.chemical_elementspectrum analysis[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]Nuclear physics0103 physical sciencesstructure[PHYS.PHYS.PHYS-INS-DET]Physics [physics]/Physics [physics]/Instrumentation and Detectors [physics.ins-det]010306 general physicsnumerical calculationssignal processingPseudovectorkryptonnucleus: semileptonic decayleaddetector010308 nuclear & particles physicsbackgroundscreeningDecay data measurementshell modelnuclear matter: effectdark matter: detector[INFO.INFO-MO]Computer Science [cs]/Modeling and Simulationcoupling: axial-vectorxenonmetrologychemistry13. Climate actionspectralelectron: energy spectrum
researchProduct

Cancer Signaling Transcriptome Is Upregulated in Type 2 Diabetes Mellitus

2020

We aimed to explore the differences in the whole transcriptome of peripheral blood mononuclear cells between elderly individuals with and without type 2 diabetes (T2D). We conducted a microarray-based transcriptome analysis of 19 individuals with T2D and 15 without. Differentially expressed genes according to linear models were submitted to the Ingenuity Pathway Analysis system to conduct a functional enrichment analysis. We established that diseases, biological functions, and canonical signaling pathways were significantly associated with T2D patients when their logarithms of Benjamini&ndash

endocrine system diseasesMicroarrayIntegrinT cellslcsh:Medicine030209 endocrinology & metabolismInflammationPeripheral blood mononuclear cellArticleDiabetis no-insulinodependentTranscriptome03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDownregulation and upregulationmedicinecancerNon-insulin-dependent diabetesCàncer030304 developmental biologyCancer0303 health sciencesbiologybusiness.industrylcsh:Rnutritional and metabolic diseasesGeneral Medicinesignaling pathwayschemistryCèl·lules TGuanosine diphosphateCancer researchbiology.proteintype 2 diabetesmedicine.symptomSignal transductionbusinesstranscriptomemicroarray
researchProduct

RAGE Mediates a Novel Proinflammatory Axis

1999

S100/calgranulin polypeptides are present at sites of inflammation, likely released by inflammatory cells targeted to such loci by a range of environmental cues. We report here that receptor for AGE (RAGE) is a central cell surface receptor for EN-RAGE (extracellular newly identified RAGE-binding protein) and related members of the S100/calgranulin superfamily. Interaction of EN-RAGEs with cellular RAGE on endothelium, mononuclear phagocytes, and lymphocytes triggers cellular activation, with generation of key proinflammatory mediators. Blockade of EN-RAGE/RAGE quenches delayed-type hypersensitivity and inflammatory colitis in murine models by arresting activation of central signaling pathw…

endocrine system diseasesbiologyBiochemistry Genetics and Molecular Biology(all)nutritional and metabolic diseasesInflammationS100A12 ProteinGeneral Biochemistry Genetics and Molecular BiologyCell biologyRAGE (receptor)Proinflammatory cytokineCell surface receptorImmunologycardiovascular systembiology.proteinmedicineCalgranulincardiovascular diseasesmedicine.symptomSignal transductionReceptorhuman activitiesCell
researchProduct

The Role of the α Cell in the Pathogenesis of Diabetes: A World beyond the Mirror

2021

Type 2 Diabetes Mellitus (T2DM) is one of the most prevalent chronic metabolic disorders, and insulin has been placed at the epicentre of its pathophysiological basis. However, the involvement of impaired alpha (α) cell function has been recognized as playing an essential role in several diseases, since hyperglucagonemia has been evidenced in both Type 1 and T2DM. This phenomenon has been attributed to intra-islet defects, like modifications in pancreatic α cell mass or dysfunction in glucagon’s secretion. Emerging evidence has shown that chronic hyperglycaemia provokes changes in the Langerhans’ islets cytoarchitecture, including α cell hyperplasia, pancreatic beta (β) cell dedifferentiati…

endocrine system diseasesmedicine.medical_treatmentReviewGlucagon-Like Peptide 1Insulin-Secreting CellsHyperglycaemiaBiology (General)SpectroscopyLangerhans’ isletsGlucagon secretionType 2 diabetesGeneral MedicineComputer Science ApplicationsChemistryAutocrine Communicationtype 2 diabeteshormones hormone substitutes and hormone antagonistsmedicine.medical_specialtyendocrine systemQH301-705.5GlucagonCatalysisInorganic ChemistryParacrine signallingInsulin resistanceInternal medicineDiabetes mellitusParacrine CommunicationmedicineAnimalsHumansHypoglycemic AgentsPhysical and Theoretical ChemistryQD1-999Molecular BiologyDipeptidyl-Peptidase IV Inhibitorsbusiness.industryInsulinOrganic ChemistryType 2 Diabetes Mellitusmedicine.diseaseGlucagonEndocrinologyDiabetes Mellitus Type 1Diabetes Mellitus Type 2Glucagon-Secreting CellsbusinessHypoglycaemiahyperglycaemiaHyperglucagonemiahypoglycaemiaInternational Journal of Molecular Sciences
researchProduct

RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development

2012

The Ras association domain family 1 isoform A (RASSF1A) is a tumor suppressor whose inactivation is implicated in the development of many human cancers, including breast carcinomas. Little is known about the tumor-suppressive function of RASSF1A in breast tissue and whether its inactivation is mechanistically involved in the initiation and progression of breast tumors. Here, we show that RASSF1A inhibits breast cancer growth in vivo, and suppresses estrogen receptor (ERα) expression and function. Reconstitution of RASSF1A in MCF7 cells led to decreased ERα levels and reduced sensitivity to estrogen (E2). Concomitantly, we observed decreased expression of Id1 as well as the E2-responsive gen…

endocrine systemCancer Researchmedicine.medical_specialtyCell SurvivalGene ExpressionEstrogen receptorApoptosisBreast NeoplasmsCell Cycle ProteinsMice SCIDBiologyMiceBreast cancerDownregulation and upregulationMice Inbred NODInternal medicineGeneticsmedicineAnimalsHumansFulvestrantMolecular BiologyCellular SenescenceCell ProliferationRegulation of gene expressionEstradiolFulvestrantTumor Suppressor ProteinsEstrogen AntagonistsEstrogen Receptor alphaCancerEstrogensCell Cycle Checkpointsmedicine.diseaseGene Expression Regulation NeoplasticEndocrinologyProteolysisMCF-7 CellsCancer researchFemaleEctopic expressionEstrogen receptor alphaNeoplasm TransplantationSignal Transductionmedicine.drugOncogene
researchProduct

Sterigmatocystin: Occurrence, toxicity and molecular mechanisms of action – A review

2020

The mycotoxin sterigmatocystin (STE) is produced mainly by Aspergillus fungi. It has been reported to occur in grains and grain-based products, cheese, coffee, spices and beer. The STE is a known biogenic precursor of aflatoxin B1, sharing with it several structural and biological similarities. The STE has been shown to be hepatotoxic and nephrotoxic in animals and it has been classified as possible human carcinogen (group 2B) by IARC. The STE has been reported to cause a marked decrease in cell proliferation in different mammalian cells. Data available on literature suggest that the cellular mechanisms underlying STE-induced toxicity include the induction of oxidative stress, mitochondrial…

endocrine systemCell cycle checkpointDNA damageSterigmatocystinApoptosisFood ContaminationPharmacologyBiologyToxicologymedicine.disease_causeAntioxidants03 medical and health scienceschemistry.chemical_compound0404 agricultural biotechnologymedicineAnimalsHumansMycotoxinCarcinogen030304 developmental biology0303 health sciencesCell Cycle04 agricultural and veterinary sciencesGeneral MedicineMycotoxins040401 food scienceBiosynthetic PathwaysMitochondriaOxidative StresschemistryApoptosisImmune SystemToxicityCarcinogensOxidative stressDNA DamageSignal TransductionFood ScienceSterigmatocystinFood and Chemical Toxicology
researchProduct

Nuclear calcium signaling by inositol trisphosphate in GH3 pituitary cells

2008

It has been proposed that nuclear and cytosolic Ca2+ ([Ca2+]N and [Ca2+]C) may be regulated independently. We address here the issue of whether inositol trisphosphate (IP3) can, bypassing changes of [Ca2+]C, produce direct release of Ca2+ into the nucleoplasm. We have used targeted aequorins to selectively measure and compare the changes in [Ca2+]C and [Ca2+]N induced by IP3 in GH3 pituitary cells. Heparin, an IP3 inhibitor that does not permeate the nuclear pores, abolished the [Ca2+]C peaks but inhibited only partly the [Ca2+]N peaks. The permeant inhibitor 2-aminoethoxy-diphenyl-borate (2-APB) blocked both responses. Removal of ATP also inhibited more strongly the [Ca2+]C than [Ca2+]N pe…

endocrine systemCytoplasm[SDV.OT]Life Sciences [q-bio]/Other [q-bio.OT]PhysiologyAequorinNucleoplasmic reticulumaequorinInositol 145-TrisphosphateCell Line03 medical and health scienceschemistry.chemical_compound0302 clinical medicinenuclear signal transductionmedicineAnimalsInositol 145-Trisphosphate Receptorsinositol trisphosphate receptorsCalcium SignalingReceptorMolecular Biology030304 developmental biologyCell Nucleus0303 health sciencesNucleoplasmbiologypituitary cellsInositol trisphosphateCell Biologyherpes simplex virusMolecular biologyRatsCytosolmedicine.anatomical_structurechemistryCytoplasmPituitary Glandbiology.proteinnucleoplasmic reticulumNucleus030217 neurology & neurosurgery
researchProduct

A mutation in the second intracellular loop of the pituitary adenylate cyclase activating polypeptide type I receptor confers constitutive receptor a…

2000

AbstractThe pituitary adenylate cyclase activating polypeptide (PACAP) type I receptor belongs to the glucagon/secretin/vasoactive intestinal polypeptide (VIP) receptor family. We mutated and deleted an amino acid residue (E261) which is located within the second intracellular loop of the rat PACAP type I receptor and which is highly conserved among the receptor family. The wild-type receptor and the mutant receptors were efficiently expressed at the surface of COS-7 cells at nearly the same level and revealed the same high affinity for the agonist PACAP-27. The cAMP contents of COS cells transfected with the E261A, E261Q, and the deletion mutant receptor were 4.6-, 5.7-, and 6.7-fold highe…

endocrine systemGrowth-hormone-releasing hormone receptorMolecular Sequence DataReceptors Pituitary Adenylate Cyclase-Activating PolypeptideBiophysicsGlutamic AcidSignal transductionTransfectionBiochemistryBeta-1 adrenergic receptorConstitutive activityStructural BiologycAMPCyclic AMPGeneticsEnzyme-linked receptorAnimals5-HT5A receptorAmino Acid SequenceReceptors Pituitary HormoneMolecular BiologySequence DeletionPeptide hormone receptorSite-directed mutagenesisPituitary adenylate cyclase activating polypeptideChemistryLiver receptor homolog-1Cell BiologyMolecular biologyRatsInterleukin-21 receptorCOS CellsMutagenesis Site-DirectedEstrogen-related receptor gammaSequence AlignmentGlucagon receptor familyhormones hormone substitutes and hormone antagonistsAdenylyl CyclasesReceptors Pituitary Adenylate Cyclase-Activating Polypeptide Type IFEBS Letters
researchProduct

Retinoids as a Perspective in Treatment of Alzheimer’s Disease

2010

<i>Background:</i> In the past, we demonstrated that the disintegrin metalloproteinase ADAM10 has α-secretase activity in vitro and in cultured cells. We also found out that moderate overexpression of this proteinase inhibits Aβ peptide production and prevents the formation of amyloid plaques in an Alzheimer’s disease (AD) mouse model. Moreover, it corrects early hippocampal defects like LTP impairment and increases cortical synaptogenesis. <i>Objective:</i> Upregulation of ADAM10 might be an alternative approach concerning AD therapy. Our current research therefore focuses on substances and/or pathways which regulate ADAM10 gene expression. <i>Methods:</i&g…

endocrine systemMorpholinesADAM10DiseaseBiologyADAM10 ProteinMiceNeuroblastomaRetinoidsPromoter activityCell Line TumorDisintegrinAnimalsHumansEnzyme InhibitorsMetalloproteinaseDose-Response Relationship DrugTerpenesPerspective (graphical)Membrane ProteinsVitaminshumanitiesIn vitroUp-Regulationcarbohydrates (lipids)ADAM ProteinsNeurologyChromonesImmunologyCancer researchbiology.proteinNeurology (clinical)Amyloid Precursor Protein SecretasesSignal TransductionNeurodegenerative Diseases
researchProduct